Related Experiment Video
Updated: Nov 17, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
COVID-19: Current knowledge in clinical features, immunological responses, and vaccine development
Ramandeep Singh1, Alisha Kang1, Xiangqian Luo1,2
1McMaster Immunology Research Centre, M. G. DeGroote Institute for Infectious Disease Research & Department of Medicine, McMaster University, Hamilton, ON, Canada.
This comprehensive review synthesizes the latest information on COVID-19, covering epidemiology, clinical features, pathogenesis, immune responses, and vaccine development for SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). It aims to provide a unified understanding of the pandemic and its mitigation strategies.
Area of Science:
- * Virology and Epidemiology
- * Immunology
- * Vaccinology
Background:
- * The COVID-19 pandemic, caused by SARS-CoV-2, represents a significant global health crisis.
- * Over 100 million infections and 2.15 million deaths were reported globally within 11 months.
- * Rapid development of vaccines occurred alongside efforts to understand natural immunity.
Purpose of the Study:
- * To provide a comprehensive overview of COVID-19.
- * To synthesize current knowledge on epidemiology, clinical features, pathogenesis, and immune responses.
- * To review the current status of COVID-19 vaccine development.
Main Methods:
- * Literature review of recent scientific publications.
- * Synthesis of data on global epidemiology and mitigation strategies.
- * Analysis of clinical features, viral pathogenesis, and immune responses.
- * Assessment of the current state of vaccine development and deployment.
Main Results:
- * Unprecedented speed in the development and emergency use authorization of multiple COVID-19 vaccines.
- * Ongoing research into viral characteristics, host immunity, and effective therapeutic strategies.
- * Global efforts focused on epidemiological surveillance and public health interventions.
Conclusions:
- * A comprehensive understanding of COVID-19 requires integrating diverse scientific information.
- * Vaccine development represents a critical tool in managing the pandemic.
- * Continued research is essential for addressing the evolving challenges of SARS-CoV-2.
Related Concept Videos
Vaccinations
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...

